Previous 10 | Next 10 |
TransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference PR Newswire ANDOVER, Mass. , July 26, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant the...
TransMedics to Report Second Quarter 2023 Financial Results on August 3, 2023 PR Newswire ANDOVER, Mass. , July 20, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplan...
2023-07-05 17:32:16 ET Gainers: Cardlytics, Inc. ( NASDAQ: CDLX ) +9% . Autolus Therapeutics ( AUTL ) +5% . Omeros ( OMER ) +4% . Arrival ( ARVL ) +3% . Nkarta ( NKTX ) +3% . Losers: IDEAYA Biosciences ( IDYA ...
2023-05-20 23:38:26 ET Summary TransMedics presents an intriguing investment opportunity due to its ongoing efforts in international expansion and consistent three-year growth trend in overseas revenue. The company currently maintains a 'hold' position from me based on its current...
TransMedics Group, Inc. (NASDAQ: TMDX) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.75% on the day to $75.72. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure...
2023-05-09 03:54:13 ET TransMedics Group ( NASDAQ: TMDX ) upsizes and prices of $400M aggregate principal amount of convertible senior unsecured notes that will mature on June 1, 2028. The offering was upsized from the previously announced offering size of $300M aggregate ...
TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028 PR Newswire ANDOVER, Mass. , May 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant th...
2023-05-08 08:17:24 ET MDJM ( MDJH ) -27% . Catalent ( CTLT ) -20% on rejecting TRC Capital's tender offer for shares BioXcel Therapeutics ( BTAI ) -15% after Q1 earning release . Baosheng Media Group Holdings ( BAOS ) -13% . Minim (...
2023-05-08 08:07:09 ET TransMedics Group ( NASDAQ: TMDX ) fell ~5% pre-market Monday after the maker of organ care systems announced a proposed offering of $300M of senior convertible notes that will mature on June 1, 2028. The offering available for qualified institutiona...
TransMedics Group, Inc. Announces Proposed Offering of $300 Million of Convertible Senior Notes Due 2028 PR Newswire ANDOVER, Mass. , May 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transfor...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...